Emily Glover Dr Kate Smith-Jackson Dr Vicky Brocklebank Dr Valerie Wilson Dr Patrick Walsh et al. | Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome | 2023 |
|
Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson Dr Thomas Hallam Professor Kevin Marchbank et al. | Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study | 2023 |
|
Dr Thomas Hallam Tom Cox Dr Kate Smith-Jackson Dr Vicky Brocklebank April Baral et al. | A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in Age-related Macular Degeneration | 2022 |
|
Dr Edwin Wong Thomas Hallam Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson et al. | Functional characterisation of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G and AMD | 2021 |
|
Dr Ola Kamala Dr Thomas Hallam Tom Cox Dr Yi Yang Dr Falguni Vyas et al. | Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice | 2021 |
|
Tom Hallam Gladys - Nik Tzoumas David Steel Victoria Shuttleworth et al. | The Rare C9 P167S Risk Variant for Age-related Macular Degeneration Increases Polymerization of the Terminal Component of the Complement Cascade | 2021 |
|
Dr Vicky Brocklebank Dr Kate Smith-Jackson Dr Patrick Walsh Professor Kevin Marchbank Professor Claire Harris et al. | Long-term outcomes and response to treatment in DGKE nephropathy | 2020 |
|
Dr Kate Smith-Jackson Dr Yi Yang Harriet Denton Katie Cooke Professor David Kavanagh et al. | Hyper-functional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice | 2019 |
|
Dr Kate Smith-Jackson Professor Kevin Marchbank
| Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab? | 2019 |
|
Dr Yi Yang Harriet Denton Dr Owen Davies Dr Kate Smith-Jackson Professor Kevin Marchbank et al. | An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy | 2018 |
|
Dr Kate Smith-Jackson Harriet Denton Professor Kevin Marchbank
| A novel C3 gain of function mouse model of atypical haemolytic uraemic syndrome | 2016 |
|
Dr Valerie Wilson Tom Cox Dr Kate Smith-Jackson Professor David Kavanagh Professor Tim Goodship et al. | Chromosomal rearrangement – a rare cause of complement factor I associated atypical haemolytic uraemic syndrome | 2016 |
|
Professor David Kavanagh Dr Kate Smith-Jackson
| Eculizumab in children with hemolytic uremic syndrome | 2016 |
|